Becker's Healthcare August 27, 2024
Eli Lilly has started selling single-dose vials of its blockbuster weight loss drug Zepbound for roughly half of its usual monthly list price.
Patients with a prescription who are paying out of pocket can now purchase a month’s supply of the drug through LillyDirect — the company’s direct-to-consumer platform that launched in January. Eli Lilly is offering a four-week supply of 2.5-milligram and 5-milligram single-dose vials for $399 and $549, respectively. The list prices for GLP-1 weight loss drugs are typically around $1,000 a month.
“This new option helps millions of adults with obesity access the medicine they need, including those not eligible for the Zepbound savings card program, those without employer coverage and those who need to self-pay...
Today's Sponsors
Today's Sponsor